Journey Medical Corp. Files 2024 10-K
Ticker: DERM · Form: 10-K · Filed: Mar 27, 2025 · CIK: 1867066
Sentiment: neutral
Topics: 10-k, financials, pharmaceutical
TL;DR
JMC filed its 2024 10-K. Financials for Dec 31, 2024 are in. Check it out.
AI Summary
Journey Medical Corp. filed its 2024 10-K on March 27, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The company, incorporated in Delaware and headquartered in Scottsdale, AZ, operates in the pharmaceutical preparations sector. Key financial data includes figures related to common stock, retained earnings, and additional paid-in capital for the years 2022, 2023, and 2024.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Journey Medical Corp.'s financial health and operational performance for the fiscal year 2024, crucial for investment decisions.
Risk Assessment
Risk Level: low — This is a standard annual financial filing with no immediate red flags or significant new risks highlighted.
Key Numbers
- 6000000 — Common Stock (Reported value for common stock)
- 13323952 — Retained Earnings (Reported value for retained earnings)
- 16153610 — Additional Paid-in Capital (Reported value for additional paid-in capital)
Key Players & Entities
- Journey Medical Corp. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-03-27 (date) — Filing date
- Scottsdale, AZ (location) — Company headquarters
- 480-434-6670 (phone_number) — Business phone number
FAQ
What was Journey Medical Corp.'s total revenue for the fiscal year ending December 31, 2024?
The provided text does not explicitly state the total revenue for the fiscal year ending December 31, 2024.
What is the company's net income or loss for the fiscal year 2024?
The filing excerpt does not contain information regarding the company's net income or loss for 2024.
Were there any significant acquisitions or divestitures reported in the 2024 10-K?
The provided text does not mention any acquisitions or divestitures.
What are the details of Journey Medical Corp.'s debt obligations as of December 31, 2024?
Information regarding the company's debt obligations is not present in this excerpt.
What were the key drivers of financial performance in 2024 for Journey Medical Corp.?
The excerpt focuses on balance sheet items and does not detail the drivers of financial performance for 2024.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 27, 2025 regarding Journey Medical Corp (DERM).